Baxalta US INC.:1276806 [20-003068]

Ended Awarded Last action

Contract number
75N90020F00019
Awardee
Awarding agency
Obligated
$11,016

Award facts

Contract value 100% obligated
$11,015.84 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bannockburn, IL 60015, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institutes of Health Clinical Center issued a $11,015.84 delivery order to Baxalta US Inc. on December 13, 2019, under the GSA Pharmaceuticals and Drugs schedule contract (FSS-61-IB) for pharmaceutical supply.

Place of performance is Bannockburn, IL. The order has a firm fixed price and an ultimate completion date of December 27, 2019. No set-aside was used.

Quick answers

Who was awarded contract 75N90020F00019?

75N90020F00019 was awarded to Baxalta US Inc. by NIH Clinical Center (National Institutes of Health) on December 13, 2019.

How much is contract 75N90020F00019 worth?

The government has obligated $11,016 on 75N90020F00019.

Is contract 75N90020F00019 an order under another contract?

Yes. 75N90020F00019 is a delivery order under V797P2140D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75N90020F00019 competed?

The extent of competition for 75N90020F00019 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award